KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Tax Provisions (2016 - 2022)

Arbutus Biopharma's Tax Provisions history spans 4 years, with the latest figure at $4.4 million for Q1 2022.

  • For Q1 2022, Tax Provisions changed N/A year-over-year to $4.4 million; the TTM value through Dec 2022 reached $4.4 million, changed N/A, while the annual FY2022 figure was $4.4 million, N/A changed from the prior year.
  • Tax Provisions for Q1 2022 was $4.4 million at Arbutus Biopharma, up from -$4.3 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $4.4 million in Q1 2022 and bottomed at -$4.3 million in Q3 2018.